Memorial Sloan-Kettering Cancer Center;Eureka Therapeutics, Inc.
发明人:
BRENTJENS, Renier, J.,SMITH, Eric, L.,LIU, Cheng
申请号：
EP16871553
公开号：
EP3383913A4
申请日:
2016.12.02
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The presently disclosed subject matter provides fully human antibodies or antigen-binding fragments thereof that bind to FcRL5 and methods of using the same.
